Chimeric Therapeutics Ltd. (AU:CHM) has released an update.
Don't Miss Our Christmas Offers:
- Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Chimeric Therapeutics Ltd. has announced the quotation of 555,009,026 fully paid ordinary shares on the Australian Securities Exchange (ASX), effective from December 9, 2024. This development is part of previously announced transactions and is set to enhance the trading activity of Chimeric’s shares, potentially attracting more investors. The move reflects the company’s strategic efforts to expand its market presence.
For further insights into AU:CHM stock, check out TipRanks’ Stock Analysis page.